Evidence map›Paper›PMID 39715810›Full record

ArticleNPJ digital medicine2024

Improving access to cardiovascular care for 1.4 billion people in China using telehealth.

Xiaohang Liu, Wei Chen, Yu Qiu, Xiang Li, Fei Liu, Zhili Jiang, Fuwei Jia, Chenggang Wang, Rongrong Ji, Tawquir R Nawaz and 4 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Multimodal Wearable Biosensing Meets Multidomain AI: A Pathway to Decentralized Healthcare.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaohang Liu *Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China.
Wei Chen *Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China.
Yu Qiu *Department of Hematology, China Japan Friendship Hospital, 2 Yinghuayuan E St, Chaoyang District, Beijing, 100029, China.
Xiang Li *Division of Cardiology, Anzhen Hospital, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Fei Liu *Division of Cardiology, Anzhen Hospital, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Zhili Jiang *Division of Cardiology, Anzhen Hospital, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Fuwei JiaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China.
Chenggang WangDivision of Cardiology, Anzhen Hospital, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Rongrong JiLead Medical, Bldg. 6, Fengchuang Science Park, Beijing Economic and Technological Development Zone, Daxing District, Beijing, 101111, China.
Tawquir R NawazLead Medical, Bldg. 6, Fengchuang Science Park, Beijing Economic and Technological Development Zone, Daxing District, Beijing, 101111, China.
Dingding ZhangDepartment Epidemiology and Biostatistics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China.
Yong ZengDivision of Cardiology, Anzhen Hospital, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Hai GaoDivision of Cardiology, Anzhen Hospital, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China. Gaohai71@hotmail.com.
Jeffrey HsuLead Medical, Bldg. 6, Fengchuang Science Park, Beijing Economic and Technological Development Zone, Daxing District, Beijing, 101111, China.

Funding

China Postdoctoral Science Foundation 2024M750246China Postdoctoral Science Foundation GZC20230298Peking Union Medical College Hospital (PUMCH) PUMCH-2024-009
6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) pose a significant health burden in China, where the large population and vast geography limit access to care. Telehealth (tHealth) services provide a virtual model of care that can enhance CVD management. This study aims to describe the trajectory of tHealth services for cardiovascular care between 2016 and 2020 in China, assess their utilization, and discuss their implications for improving access to care in resource-scarce regions. Data were collected on patient-facing, operational tHealth apps in Mainland China. In 2016, 45.8% of tertiary hospitals were accessible via tHealth apps, with a 10.7% annual growth rate. Wealthier regions had better tHealth coverage, irrespective of CVD burden. In 2016 and 2020, 34% and 67% of patients, respectively, consulted doctors located outside of their provinces, primarily in wealthier areas. The most common CVDs managed were hypertension, coronary artery disease, and arrhythmia. These findings suggest that tHealth services improve care access, especially in underdeveloped regions, but widespread technology adoption remains crucial.

Identifiers

PMID39715810
PMCPMC11666715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.